A war of words is simmering between the Chilean government and the pharmaceutical industry over steps the South American country is considering to control rising drug costs.

In recent remarks, Jose Ramon Valente Vias, the minister of Economy, Development, and Tourism, pushed back against the latest effort by the PhRMA industry trade group to convince the U.S. Trade Representative to keep Chile on its annual list of countries that fail to protect and enforce patent rights. The U.S. Trade Rep is due to release its latest so-called U.S. Priority Watch list shortly.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy